Smith Group Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Smith Group Asset Management's BIIB Position: Q1 2025 in Review
Smith Group Asset Management sold out of Biogen (BIIB) in Q1 2025, closing a stake of 2,000 shares — an estimated $306K sold.
Smith Group Asset Management first reported a position in BIIB in Q2 2013 and held it in 20 quarters. The position peaked at $71.2M in Q4 2017. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.
- Smith Group Asset Management reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
- Smith Group Asset Management sold 2,000 Biogen shares in Q1 2025, an estimated $306K.
- Smith Group Asset Management first reported a position in Biogen in Q2 2013 and held it in 20 quarters.
- Smith Group Asset Management's Biogen position peaked at $71.2M in Q4 2017.
- 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.
Based on Smith Group Asset Management's 13F filing for Q1 2025, filed 28 Apr 2025.